{"result": "Here is a comprehensive summary of the data:\n\nHDCT (High-Dose Chemotherapy Treatment) is a chemotherapy treatment used in high-dose trials, specifically evaluated in clinical trials for the treatment of Inflammatory Breast Cancer (IBC). It is a high-dose chemotherapy regimen that includes epirubicin and cyclophosphamide with G-CSF support. HDCT is a treatment strategy for IBC patients, involving high-dose chemotherapy, but it is not commonly used in IBC clinics.", "input": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we the have full context.\n\n#######\n-Data-\nEntities: \"\\\"HDCT\\\"\"\nDescription List: [\"\", \"\\\"HDCT is a chemotherapy treatment used in high-dose trials, but not commonly used in IBC clinics.\\\"\", \"\\\"HDCT is a high-dose chemotherapy regimen that includes epirubicin and cyclophosphamide with G-CSF support.\\\"\", \"\\\"HDCT is a treatment strategy evaluated in clinical trials for the treatment of IBC.\\\"\", \"\\\"HDCT is a type of treatment for IBC patients, involving high-dose chemotherapy.\\\"\"]\n#######\nOutput:\n", "parameters": {"model": "llama3-8b-8192", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 500, "n": null}}